These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11200359)

  • 1. The effects of a mechanical thrombolytic device on normal canine vein valves.
    McLennan G; Trerotola SO; Davidson D; Rhodes CA; Lazzaro C; Dreesen J; Tennery G; Lane KA
    J Vasc Interv Radiol; 2001 Jan; 12(1):89-94. PubMed ID: 11200359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical in vivo testing of the Arrow-Trerotola percutaneous thrombolytic device for venous thrombosis.
    Trerotola SO; McLennan G; Davidson D; Lane KA; Ambrosius WT; Lazzaro C; Dreesen J
    J Vasc Interv Radiol; 2001 Jan; 12(1):95-103. PubMed ID: 11200360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injury potential to venous valves from the Amplatz thrombectomy device.
    Sharafuddin MJ; Gu X; Han YM; Urness M; Gunther R; Amplatz K
    J Vasc Interv Radiol; 1999 Jan; 10(1):64-9. PubMed ID: 10872492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vein rupture by Arrow-Trerotola percutaneous thrombolytic device in a treatment of thrombosed arteriovenous graft.
    Hong YK; Kang KH; Kim TH; Yang HC
    J Vasc Access; 2018 Jul; 19(4):396-397. PubMed ID: 29529963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early experimental experience with a surgically created, totally autogenous venous valve: a preliminary report.
    Rosenbloom MS; Schuler JJ; Bishara RA; Ronan SG; Flanigan DP
    J Vasc Surg; 1988 May; 7(5):642-6. PubMed ID: 3367428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of thrombosed hemodialysis access grafts: Arrow-Trerotola percutaneous thrombolytic device versus pulse-spray thrombolysis. Arrow-Trerotola Percutaneous Thrombolytic Device Clinical Trial.
    Trerotola SO; Vesely TM; Lund GB; Soulen MC; Ehrman KO; Cardella JF
    Radiology; 1998 Feb; 206(2):403-14. PubMed ID: 9457193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Descending phlebography in patients with venous ulceration: hemodynamic implications.
    Papadakis KG; Christopoulos D; Hobbs JT; Nicolaides AN
    Int Angiol; 2015 Jun; 34(3):263-8. PubMed ID: 25877427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension-induced venous valve remodeling.
    Takase S; Pascarella L; Bergan JJ; Schmid-Schönbein GW
    J Vasc Surg; 2004 Jun; 39(6):1329-34. PubMed ID: 15192576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular injury caused by mechanical thrombectomy in porcine arteries: AKónya eliminator device versus Arrow-Trerotola percutaneous thrombolytic device.
    Kónya A; Choi BG; Van Pelt CS; Wright KC
    J Vasc Interv Radiol; 2006 Jan; 17(1):121-34. PubMed ID: 16415141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous venous thrombectomy using the Arrow-Trerotola percutaneous thrombolytic device (PTD) with temporary caval filtration: in vitro investigations.
    Wildberger JE; Haage P; Bovelander J; Pfeffer J; Weiss C; Vorwerk D; Schmitz-Rode T; Günther RW
    Cardiovasc Intervent Radiol; 2005; 28(2):221-7. PubMed ID: 15883861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An animal model of venous hypertension: the role of inflammation in venous valve failure.
    Pascarella L; Schmid-Schönbein GW; Bergan J
    J Vasc Surg; 2005 Feb; 41(2):303-11. PubMed ID: 15768014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valvular obstruction of blood flow through saphenous veins.
    Walsh DB; Downing S; Ahmed SW; Wallace RB
    J Surg Res; 1987 Jan; 42(1):39-42. PubMed ID: 3807353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory venous pressure revisited.
    Neglen P; Raju S
    J Vasc Surg; 2000 Jun; 31(6):1206-13. PubMed ID: 10842158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombosed hemodialysis grafts: lyse and wait with tissue plasminogen activator or urokinase compared to mechanical thrombolysis with the Arrow-Trerotola Percutaneous Thrombolytic Device.
    Vogel PM; Bansal V; Marshall MW
    J Vasc Interv Radiol; 2001 Oct; 12(10):1157-65. PubMed ID: 11585881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflow thrombosis does not adversely affect thrombolysis outcomes of symptomatic iliofemoral deep vein thrombosis.
    Jeyabalan G; Marone L; Rhee R; Hirsch S; Makaroun MS; Cho J; Chaer RA
    J Vasc Surg; 2011 Aug; 54(2):448-53. PubMed ID: 21620617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous deployment of a valved bovine jugular vein in the swine venous system: a potential treatment for venous insufficiency.
    Gomez-Jorge J; Venbrux AC; Magee C
    J Vasc Interv Radiol; 2000; 11(7):931-6. PubMed ID: 10928534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of short-term hemodialysis catheters on the central veins: a catheter venographic study.
    Oguzkurt L; Tercan F; Torun D; Yildirim T; Zümrütdal A; Kizilkilic O
    Eur J Radiol; 2004 Dec; 52(3):293-9. PubMed ID: 15544909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribution of valves to saphenous vein graft resistance.
    Ku DN; Klafta JM; Gewertz BL; Zarins CK
    J Vasc Surg; 1987 Sep; 6(3):274-9. PubMed ID: 3625883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolysis for experimental deep venous thrombosis maintains valvular competence and vasoreactivity.
    Rhodes JM; Cho JS; Gloviczki P; Mozes G; Rolle R; Miller VM
    J Vasc Surg; 2000 Jun; 31(6):1193-205. PubMed ID: 10842157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful tissue engineering of competent allogeneic venous valves.
    Kuna VK; Rosales A; Hisdal J; Osnes EK; Sundhagen JO; Bäckdahl H; Sumitran-Holgersson S; Jørgensen JJ
    J Vasc Surg Venous Lymphat Disord; 2015 Oct; 3(4):421-430.e1. PubMed ID: 26992620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.